Quality of life for mPCa patients undergoing treatment

In this interview recorded at UROonco24 in Budapest earlier in the year, Dr. Gianluca Giannarini (IT) talks with Prof. Geert De Meerleer (BE) about the quality of life for patients with metastatic prostate cancer (mPCa) that are undergoing treatment. Their conversation features the role and safety of radiation therapy in patients with de novo metastatic hormone sensitive prostate cancer.This activity is supported by an educational grant from a Pharmaceutical company, with no involvement in the programme or speaker selection.